InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Caribou Biosciences, Inc.

CRBU Clue Score27
United States Fiscal year ends December CIK 0001619856 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

13
Insider
Date
Role
Action
Shares
Price
Amount
Rachel E. Haurwitz
14 Mar 2025
President and CEO
Buy indirect
20,000
$1.02
$20.40K
Sriram Ryali
29 Jan 2025
Chief Financial Officer
Buy
17,360
$1.42
$24.65K
Ryan Fischesser
11 Jan 2022
VP of Finance and Controller
Buy
6,818
$4.11
$28.02K
Ryan Fischesser
11 Jan 2022
VP of Finance and Controller
Buy
569
$2.69
$1.53K
Ryan Fischesser
20 Dec 2021
VP of Finance and Controller
Buy
1,136
$2.69
$3.06K
Barbara G McClung
7 Dec 2021
Chief Legal Officer
Buy
6,115
$2.69
$16.45K
Barbara G McClung
7 Dec 2021
Chief Legal Officer
Buy
12
$2.69
$32.28
Barbara G McClung
20 Oct 2021
Chief Legal Officer
Buy
43
$2.69
$115.67
Barbara G McClung
20 Oct 2021
Chief Legal Officer
Buy
9,176
$2.69
$24.68K
Steven Kanner
12 Oct 2021
Chief Scientific Officer
Buy
14,614
$2.69
$39.31K
Steven Kanner
12 Oct 2021
Chief Scientific Officer
Buy
698
$1.81
$1.26K
Steven Kanner
12 Oct 2021
Chief Scientific Officer
Buy
99,548
$1.81
left out
Ryan Fischesser
11 Oct 2021
VP of Finance and Controller
Buy
1,746
$2.69
$4.70K
Show all 41 transactions →

What was left out

Form 4 filings counted 97
Amendments (4/A) skipped 2
Filings about a different issuer 2
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 2
Sales at will 8
Transactions with no price 1
Shares from compensation/vesting 4,644,394
Sales filed before the plan box existed 1
History held since 11 May 2016